News Bulbitech is FDA registered Bulbitech is FDA registered under number D437315
Article / News Bulbitech featured in exclusive life science report: Unlocking potential in Norway Dennis Hens, the Dutch CEO of Norwegian neuro-opthalmology device player Bulbitech, outlines the company’s journey to market, how its technology can support both optometrists and neurologists in their work, and gives an overview of the investment landscape for innovative medtech in […]
Article / News A Single Neuro-ocular Diagnostic Device for Multiple Examinations 2021 starts with Medical Tech Outlook editorial board assessing and shortlisting Bulbitech’s solution in their top 10 Screening and Testing Solution provider in Europe. Pls read the interview they had with our CEO Dennis Hens. In the past decade, rapid technological advancements have significantly […]
University Medical Centre Groningen’s (UMCG) Laboratory of Experimental Ophthalmology (LEO) and Bulbitech AS to collaborate on the evaluation of eye movement based ophthalmic screening techniques. Facilitated by an equipment grant from the UMCG, the Laboratory of Experimental Ophthalmology (LEO) has signed an agreement with Norwegian start-up Bulbitech AS (www.bulbitech.com) to buy their innovative BulbiCAM. The […]
Are you ready to automate and quantify your entrance tests and functional eye examination tests? We’re finalizing the last stage of hardware R&D and planned to be CE-approved in Q1-2021. Please find our brochure below and plan your online demo.
Article / News Dennis Hens – CEO, Bulbitech Dennis Hens, the Dutch CEO of Norwegian neuro-opthalmology device player Bulbitech, outlines the company’s journey to market, how its technology can support both optometrists and neurologists in their work, and gives an overview of the investment landscape for innovative medtech in Norway. “Norway is a very good […]
Article / News Summary Validity & reliability of testdata BulbiCAM Trondheim 19.11.2020 Chennai 19.11.2020 Oslo 19.11.2020 Video Oculography Device (VOG) BulbiCAM shows good to excellent agreement in the validation of inter-observer reliability between devices and stability of all measurements, during visual field testing, pupil testing and testing of eye ptosis in a population of glaucoma […]
Article / News News The Science Behind Eye Movement Perimetry Bjørn Helland-Hansen MD, Dennis Hens Msc, Pooja Nandagopal OD In this overview article, we aim to show that Bulbitech’s approach to perimetry has a sound physiological and empirical basis, ratified by peer-reviewed articles. We assume a basic knowledge of glaucoma and perimetry, and will follow […]
Article / News Summary Validity & reliability of testdata BulbiCAM After winning the Oslo Innovation Week Bulbitech’s management were interviewed by journalist Gunnar Okstad on the potential of Bulbitech’s neuro-ophthalmic eye-tracking device for investors, patients and clinical users. (in Norwegian) Bulbitech: Petter Ulleberg (til høyre), Bård Dalhøi og Dennis Hens (på skjermen til venstre) er […]
BulbiTech AS has been selected as the winner of the healthtrack 100 pitches at the Oslo Innovation Week.